Association of Graves' disease and thymic hyperplasia and the role of TSH receptor antibodies in T cell development

Completed

• Conditions: thymus hyperplasie; Hyperthyroidism; 10043739

• Registration Number: NL-OMON35294
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Graves' disease
radioactive iodine treatment

Exclusion Criteria

use of corticosteroids
older than 50 years of age
psychiatric diseases
pregnancy

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Presence of thymic hyperplasia.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Increase of naive T cells in the blood.<br /><br>Increase in TRECs in the blood.</p><br>